What is the mechanism of action for SABA medications?

What is the mechanism of action for SABA medications?

• A. Inhibits leukotriene production
• B. Relaxes bronchial smooth muscle
• C. Increases mucus production
• D. Decreases inflammation in the lungs

Answer: (B)

SABA medications, or Short-Acting Beta-Agonists, primarily function by relaxing bronchial smooth muscle. This action occurs because these medications stimulate beta-2 adrenergic receptors located in the airway smooth muscle, leading to muscle relaxation and subsequent dilation of the airways. This dilation improves airflow, making it easier for individuals with asthma to breathe during an acute attack or when experiencing symptoms. The mechanism of action is particularly important in asthma management, as it provides rapid relief from bronchoconstriction. SABAs are commonly used for quick relief or rescue in situations where immediate bronchodilation is necessary. Understanding this mechanism highlights the critical role of SABAs in managing asthma symptoms effectively. Other options, such as inhibiting leukotriene production, increasing mucus production, or decreasing inflammation in the lungs, do not accurately describe the specific action of SABA medications and relate more to different classes of asthma treatments or other mechanisms in asthma pathophysiology.

SABA medications, or Short-Acting Beta-Agonists, primarily function by relaxing bronchial smooth muscle. This action occurs because these medications stimulate beta-2 adrenergic receptors located in the airway smooth muscle, leading to muscle relaxation and subsequent dilation of the airways. This dilation improves airflow, making it easier for individuals with asthma to breathe during an acute attack or when experiencing symptoms.

The mechanism of action is particularly important in asthma management, as it provides rapid relief from bronchoconstriction. SABAs are commonly used for quick relief or rescue in situations where immediate bronchodilation is necessary. Understanding this mechanism highlights the critical role of SABAs in managing asthma symptoms effectively.

Other options, such as inhibiting leukotriene production, increasing mucus production, or decreasing inflammation in the lungs, do not accurately describe the specific action of SABA medications and relate more to different classes of asthma treatments or other mechanisms in asthma pathophysiology.